Amwell, a SaaS-based digital health platform for telehealth and hybrid care delivery, released fourth-quarter and full-year 2025 results on February 12, 2026. Top-line contraction stemmed mainly from the elimination of key Defense Health Agency (DHA) programs and attrition of older contracts, while the company narrowed losses through aggressive cost reductions and a strategic shift toward […]
The post Amwell Q4 Revenue Falls 22% Amid DHA Program Cuts appeared first on LevinPro Healthcare M&A – The latest healthcare M&A news.
